Ischemia with non-obstructive coronary artery (INOCA): Non-invasive versus invasive techniques for diagnosis and the role of #FullPhysiology
- PMID: 39039011
- DOI: 10.1016/j.ejim.2024.07.017
Ischemia with non-obstructive coronary artery (INOCA): Non-invasive versus invasive techniques for diagnosis and the role of #FullPhysiology
Abstract
Ischemia with non-obstructive coronary arteries (INOCA) is an increasingly recognized entity. It encompasses different pathophysiological subtypes (i.e., endotypes), including coronary microvascular dysfunction (CMD), vasospastic angina (VSA) and mixed entities resulting from the variable combination of both. Diagnosing INOCA and precisely characterizing the endotype allows for accurate medical treatment and has proven prognostic implications. A breadth of diagnostic technique is available, ranging from non-invasive approaches to invasive coronary angiography adjuvated by functional assessment and provocative tests. This review summarizes the strength and limitations of these methodologies and provides the rationale for the routine referral for invasive angiography and functional assessment in this subset of patients.
Keywords: ANOCA; Coronary flow reserve; Coronary microcirculation; Coronary physiology; INOCA; Index of microvascular resistance.
Copyright © 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest statement Prof. Porto reports consultant or speaker fees from Medtronic, Abbott Vascular, Edwards, ABIOMED, GE, Siemens Healthcare, Sanofi, Amgen, Daiichi-Sankyo, Astra Zeneca, Bayer, and PIAM, not related to this work. Prof. Gianluca Campo reports research grants from SMT, Siemens Healthcare, GADA, Abbott Vascular, Insight Lifetech. Dr. Benenati reports speaker fees from Amgen. Other authors have nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources